Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15 196 patients. J Thorac Cardiovasc Surg. 2008;136:884 93. 190. Laurikka J, Wu ZK, Iisalo P, et al. Regional ischemic preconditioning enhances myocardial performance in off-pump coronary artery bypass grafting. Chest. 2002;121:1183 9. 191. Penttila HJ, Lepojarvi MV, Kaukoranta PK, et al. Ischemic precondi- tioning does not improve myocardial preservation during off-pump multivessel coronary operation. Ann Thorac Surg. 2003;75:1246 52. 192. Walsh SR, Tang TY, Kullar P, et al. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardiothorac Surg. 2008; 34:985 94. 193. Hausenloy DJ, Mwamure PK, Venugopal V, et al. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet. 2007;370:575 9. 194. Rahman IA, Mascaro JG, Steeds RP, et al. Remote ischemic precon- ditioning in human coronary artery bypass surgery: from promise to disappointment? Circulation. 2010;122 Suppl:S53 9. 195. Venugopal V, Hausenloy DJ, Ludman A, et al. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial. Heart. 2009;95:1567 71. 196. Luo W, Li B, Chen R, et al. Effect of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg. 2008;33:203 8. 197. Ovize M, Baxter GF, Di Lisa F, et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2010;87:406 23. 198. Mohammed AA, Agnihotri AK, van Kimmenade RR, et al. Pro- spective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery. Circulation. 2009;120:843 50. 199. Ramsay J, Shernan S, Fitch J, et al. Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves. J Thorac Cardiovasc Surg. 2005;129:300 6. 200. Yau JM, Alexander JH, Hafley G, et al. Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Trans- fection [PREVENT] IV). Am J Cardiol. 2008;102:546 51. 201. Chowdhury UK, Malik V, Yadav R, et al. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myo- globin release. J Thorac Cardiovasc Surg. 2008;135:1110 9,9. 202. Rahimi K, Banning AP, Cheng AS, et al. Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic res- onance imaging study. Heart. 2009;95:1937 43. 203. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50:2173 95. 204. Venge P, Johnston N, Lindahl B, et al. Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ische- mia. J Am Coll Cardiol. 2009;54:1165 72. 205. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357:1121 35. 206. Mentzer RM Jr, Bartels C, Bolli R, et al. Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the Expedition study. Ann Thorac Surg. 2008;85:1261 70. Hillis et al 2011 ACCF/AHA CABG Guideline e705 207. Turer AT, Hill JA. Pathogenesis of myocardial ischemiareperfusion injury and rationale for therapy. Am J Cardiol. 2010;106:360 8. 208. Ghorbel MT, Cherif M, Mokhtari A, et al. Off-pump coronary artery bypass surgery is associated with fewer gene expression changes in the human myocardium in comparison with on-pump surgery. Physiol Genomics. 2010;42:67 75. 209. Podgoreanu MV, Schwinn DA. New paradigms in cardiovascular med- icine: emerging technologies and practices: perioperative genomics. J Am Coll Cardiol. 2005;46:1965 77. 210. Castellheim A, Hoel TN, Videm V, et al. Biomarker profile in off-pump and on-pump coronary artery bypass grafting surgery in low-risk patients. Ann Thorac Surg. 2008;85:1994 2002. 211. Parolari A, Camera M, Alamanni F, et al. Systemic inflammation after on-pump and off-pump coronary bypass surgery: a one-month follow-up. Ann Thorac Surg. 2007;84:823 8. 212. Paulitsch FS, Schneider D, Sobel BE, et al. Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study. Coron Artery Dis. 2009;20:100 5. 213. Serrano CV Jr, Souza JA, Lopes NH, et al. Reduced expression of systemic proinflammatory and myocardial biomarkers after off-pump versus on-pump coronary artery bypass surgery: a prospective ran- domized study. J Crit Care. 2010;25:305 12. 214. Ghosh S, Galinanes M. Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2003;126:133 42. 215. Jenkins DP, Pugsley WB, Alkhulaifi AM, et al. Ischaemic precondi- tioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart. 1997;77:314 8. 216. Loubani M, Ghosh S, Galinanes M. The aging human myocardium: tolerance to ischemia and responsiveness to ischemic preconditioning. J Thorac Cardiovasc Surg. 2003;126:143 7. 217. Wu ZK, Iivainen T, Pehkonen E, et al. Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascular- ization. Circulation. 2002;106:3091 6. 218. Walsh SR, Tang T, Sadat U, et al. Cardioprotection by remote ischaemic preconditioning. Br J Anaesth. 2007;99:611 6. 219. Murphy GS, Szokol JW, Marymont JH, et al. Opioids and cardiopro- tection: the impact of morphine and fentanyl on recovery of ventricular function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2006;20:493 502. 220. Peart JN, Gross GJ. Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways. Am J Physiol Heart Circ Physiol. 2006;291:H1746 53. 221. Wang B, Shravah J, Luo H, et al. Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochem Biophys Res Commun. 2009;389: 105 11. 222. Xia Z, Huang Z, Ansley DM. Large-dose propofol during cardiopul- monary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane. Anesth Analg. 2006;103:527 32. 223. De Hert SG, ten Broecke PW, Mertens E, et al. sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology. 2002;97:42 9. 224. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its adminis- tration. Anesthesiology. 2004;101:299 310. 225. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthe- siology. 2004;101:9 20. 226. Garcia C, Julier K, Bestmann L, et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth. 2005; 94:159 65. 227. Julier K, da Silva R, Garcia C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo- controlled, multicenter study. Anesthesiology. 2003;98:1315 27. 228. Fillinger MP, Surgenor SD, Hartman GS, et al. The association between heart rate and in-hospital mortality after coronary artery bypass graft surgery. Anesth Analg. 2002;95:1483 8. 229. Fox K, Ford I, Steg PG, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dys- function (BEAUTIFUL): a subgroup analysis of a randomised con- trolled trial. Lancet. 2008;372:817 21. 230. Breisblatt WM, Stein KL, Wolfe CJ, et al. Acute myocardial dys- function and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol. 1990;15:1261 9. 231. Ekery DL, Davidoff R, Orlandi QG, et al. Imaging and diagnostic testing: diastolic dysfunction after coronary artery bypass grafting: a frequent finding of clinical significance not influenced by intravenous calcium. Am Heart J. 2003;145:896 902. 232. Bijker JB, van Klei WA, Kappen TH, et al. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection. Anesthesiology. 2007;107:213 20. 233. Aronson S, Stafford-Smith M, Phillips-Bute B, et al. Intraoperative systolic blood pressure variability predicts 30 day mortality in aorto- coronary bypass surgery patients. Anesthesiology. 2010;113:305 12. 234. Nikolov NM, Fontes ML, White WD, et al. Pulse pressure and long-term survival after coronary artery bypass graft surgery. Anesth Analg. 2010;110:335 40. 235. Alexiou K, Kappert U, Staroske A, et al. Coronary surgery for acute coronary syndrome: which determinants of outcome remain? Clin Res Cardiol. 2008;97:601 8. 236. Chiu FC, Chang SN, Lin JW, et al. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: a pro- pensity score analysis. J Thorac Cardiovasc Surg. 2009;138:1326 30. 237. DeWood MA, Spores J, Berg R Jr, et al. Acute myocardial infarction: a decade of experience with surgical reperfusion in 701 patients. Circulation. 1983;68:II8 16. 238. Donatelli F, Benussi S, Triggiani M, et al. Surgical treatment for life-threatening acute myocardial infarction: a prospective protocol. Eur J Cardiothorac Surg. 1997;11:228 33. 239. Filizcan U, Kurc E, Cetemen S, et al. Mortality predictors in ST-elevated myocardial infarction patients undergoing coronary artery bypass grafting. Angiology. 2011;62:68 73. 240. Chevalier P, Burri H, Fahrat F, et al. Perioperative outcome and long-term survival of surgery for acute post-infarction mitral regurgi- tation. Eur J Cardiothorac Surg. 2004;26:330 5. 241. Lemery R, Smith HC, Giuliani ER, et al. Prognosis in rupture of the ventricular septum after acute myocardial infarction and role of early surgical intervention. Am J Cardiol. 1992;70:147 51. 242. Russo A, Suri RM, Grigioni F, et al. Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. Circulation. 2008;118:1528 34. 243. Shamshad F, Kenchaiah S, Finn PV, et al. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). Am Heart J. 2010;160:145 51. 244. Tavakoli R, Weber A, Brunner-La Rocca H, et al. Results of surgery for irreversible moderate to severe mitral valve regurgitation secondary to myocardial infarction. Eur J Cardiothorac Surg. 2002;21:818 24. 245. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK Investigators: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341: 625 34. 246. Mehta RH, Lopes RD, Ballotta A, et al. Percutaneous coronary inter- vention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? Am Heart J. 2010;159:141 7. 247. White HD, Assmann SF, Sanborn TA, et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Car- diogenic Shock (SHOCK) trial. Circulation. 2005;112:1992 2001. 248. Ngaage DL, Cale AR, Cowen ME, et al. Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia. Ann Thorac Surg. 2008;85:1278 81. 249. Parikh SV, de Lemos JA, Jessen ME, et al. Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines). J Am Coll Cardiol Intv. 2010;3:419 27. 250. Lim HS, Farouque O, Andrianopoulos N, et al. Survival of elderly patients undergoing percutaneous coronary intervention for acute myo- cardial infarction complicated by cardiogenic shock. J Am Coll Cardiol Intv. 2009;2:146 52. 251. Amin AP, Nathan S, Prodduturi P, et al. Survival benefit from early revascularization in elderly patients with cardiogenic shock after acute myocardial infarction: a cohort study. J Invasive Cardiol. 2009;21: 305 12. 252. Migliorini A, Moschi G, Valenti R, et al. Routine percutaneous coronary intervention in elderly patients with cardiogenic shock com- plicating acute myocardial infarction. Am Heart J. 2006;152:903 8. 253. Hochman JS, Buller CE, Sleeper LA, et al. Cardiogenic shock com- plicating acute myocardial infarction etiologies, management and outcome: a report from the SHOCK Trial Registry: SHould we emer- gently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol. 2000;36:1063 70. 254. Dzavik V, Sleeper LA, Cocke TP, et al. Early revascularization is associated with improved survival in elderly patients with acute myo- cardial infarction complicated by cardiogenic shock: a report from the SHOCK Trial Registry. Eur Heart J. 2003;24:828 37. 255. Coskun KO, Coskun ST, Popov AF, et al. Experiences with surgical treatment of ventricle septal defect as a post infarction complication. J Cardiothorac Surg. 2009;4:3. 256. Oliva PB, Hammill SC, Edwards WD. Cardiac rupture, a clinically predictable complication of acute myocardial infarction: report of 70 cases with clinicopathologic correlations. J Am Coll Cardiol. 1993;22: 720 6. 257. Kjaergard H, Nielsen PH, Andreasen JJ, et al. Coronary artery bypass grafting within 30 days after treatment of acute myocardial infarctions with angioplasty or fibrinolysis a surgical substudy of DANAMI-2. Scand Cardiovasc J. 2004;38:143 6. 258. Stone GW, Brodie BR, Griffin JJ, et al. Role of cardiac surgery in the hospital phase management of patients treated with primary angio- plasty for acute myocardial infarction. Am J Cardiol. 2000;85:1292 6. 259. Creswell LL, Moulton MJ, Cox JL, et al. Revascularization after acute myocardial infarction. Ann Thorac Surg. 1995;60:19 26. 260. Kamohara K, Yoshikai M, Yunoki J, et al. Surgical revascularization for acute coronary syndrome: comparative surgical and long-term results. Jpn J Thorac Cardiovasc Surg. 2006;54:95 102. 261. Kjaergard HK, Nielsen PH, Andreasen JJ, et al. Coronary artery bypass grafting within the first year after treatment of large acute myocardial infarctions with angioplasty or fibrinolysis. Scand Cardiovasc J. 2006; 40:25 8. 262. Lee DC, Oz MC, Weinberg AD, et al. Optimal timing of revascular- ization: transmural versus nontransmural acute myocardial infarction. Ann Thorac Surg. 2001;71:1197 202. 263. Wasvary H, Shannon F, Bassett J, et al. Timing of coronary artery bypass grafting after acute myocardial infarction. Am Surg. 1997;63: 710 5. 264. Weiss ES, Chang DD, Joyce DL, et al. Optimal timing of coronary artery bypass after acute myocardial infarction: a review of California discharge data. J Thorac Cardiovasc Surg. 2008;135:503 11, e1 3. 265. Lee JH, Murrell HK, Strony J, et al. Risk analysis of coronary bypass surgery after acute myocardial infarction. Surgery. 1997;122:675 80. 266. Thielmann M, Neuhauser M, Marr A, et al. Predictors and outcomes of coronary artery bypass grafting in ST elevation myocardial infarction. Ann Thorac Surg. 2007;84:17 24. 267. Purcaro A, Costantini C, Ciampani N, et al. Diagnostic criteria and management of subacute ventricular free wall rupture complicating acute myocardial infarction. Am J Cardiol. 1997;80:397 405. 268. von Segesser LK, Popp J, Amann FW, et al. Surgical revascularization in acute myocardial infarction. Eur J Cardiothorac Surg. 1994;8:363 8. 269. Danner BC, Didilis VN, Stojanovic T, et al. A three-group model to predict mortality in emergent coronary artery bypass graft surgery. Ann Thorac Surg. 2009;88:1433 9. 270. Thielmann M, Massoudy P, Neuhauser M, et al. Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes. Circulation. 2006;114:I448 53. 271. Every NR, Fahrenbruch CE, Hallstrom AP, et al. influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. J Am Coll Cardiol. 1992;19:1435 9. 272. Kelly P, Ruskin JN, Vlahakes GJ, et al. Surgical coronary revascular- ization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol. 1990;15:267 73. 273. Autschbach R, Falk V, Gonska BD, et al. The effect of coronary bypass graft surgery for the prevention of sudden cardiac death: recurrent episodes after ICD implantation and review of literature. Pacing Clin Electrophysiol. 1994;17:552 8. 274. Cook JR, Rizo-Patron C, Curtis AB, et al. Effect of surgical revascu- larization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable defibrillators (AVID) Registry. Am Heart J. 2002;143:821 6. 275. Berntsen RF, Gunnes P, Lie M, et al. Surgical revascularization in the treatment of ventricular tachycardia and fibrillation exposed by exercise-induced ischaemia. Eur Heart J. 1993;14:1297 303. 276. Daoud EG, Niebauer M, Kou WH, et al. Incidence of implantable defibrillator discharges after coronary revascularization in survivors of ischemic sudden cardiac death. Am Heart J. 1995;130:277 80. 277. Budeus M, Feindt P, Gams E, et al. Risk factors of ventricular tachyarrhythmias after coronary artery bypass grafting. Int J Cardiol. 2006;113:201 8. 278. Yeung-Lai-Wah JA, Qi A, McNeill E, et al. New-onset sustained ventricular tachycardia and fibrillation early after cardiac operations. Ann Thorac Surg. 2004;77:2083 8. 279. Pires LA, Hafley GE, Lee KL, et al. Prognostic significance of non- sustained ventricular tachycardia identified postoperatively after coronary artery bypass surgery in patients with left ventricular dys- function. J Cardiovasc Electrophysiol. 2002;13:757 63. 280. Barakate MS, Bannon PG, Hughes CF, et al. Emergency surgery after unsuccessful coronary angioplasty: a review of 15 years experience. Ann Thorac Surg. 2003;75:1400 5. 281. Roy P, de Labriolle A, Hanna N, et al. Requirement for emergent coronary artery bypass surgery following percutaneous coronary inter- vention in the stent era. Am J Cardiol. 2009;103:950 3. 282. Craver JM, Weintraub WS, Jones EL, et al. Emergency coronary artery bypass surgery for failed percutaneous coronary angioplasty: a 10 year experience. Ann Surg. 1992;215:425 33. 283. Stamou SC, Hill PC, Haile E, et al. Clinical outcomes of nonelective coronary revascularization with and without cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2006;131:28 33. 284. Frutkin AD, Mehta SK, Patel T, et al. Outcomes of 1090 consecutive, elective, nonselected percutaneous coronary interventions at a com- munity hospital without onsite cardiac surgery. Am J Cardiol. 2008; 101:53 7. 285. Singh M, Gersh BJ, Lennon RJ, et al. Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience. Mayo Clin Proc. 2009;84:501 8. 286. Ting HH, Raveendran G, Lennon RJ, et al. A total of 1007 percuta- neous coronary interventions without onsite cardiac surgery: acute and long-term outcomes. J Am Coll Cardiol. 2006;47:1713 21. 287. Andreasen JJ, Mortensen PE, Andersen LI, et al. Emergency coronary artery bypass surgery after failed percutaneous transluminal coronary angioplasty. Scand Cardiovasc J. 2000;34:242 6. 288. Berger PB, Stensrud PE, Daly RC, et al. Time to reperfusion and other procedural characteristics of emergency coronary artery bypass surgery after unsuccessful coronary angioplasty. Am J Cardiol. 1995;76:565 9. 289. Carey JA, Davies SW, Balcon R, et al. Emergency surgical revascu- larisation for coronary angioplasty complications. Br Heart J. 1994;72: 428 35. 290. Hake U, Iversen S, Jakob HG, et al. influence of incremental preop- erative risk factors on the perioperative outcome of patients undergoing emergency versus urgent coronary artery bypass grafting. Eur J Car- diothorac Surg. 1989;3:162 8. 291. Talley JD, Weintraub WS, Roubin GS, et al. Failed elective percuta- neous transluminal coronary angioplasty requiring coronary artery bypass surgery. In-hospital and late clinical outcome at 5 years. Cir- culation. 1990;82:1203 13. 292. Wang N, Gundry SR, Van Arsdell G, et al. Percutaneous transluminal coronary angioplasty failures in patients with multivessel disease. Is there an increased risk? J Thorac Cardiovasc Surg. 1995;110:214 21. 293. Klepzig H Jr, Kober G, Satter P, et al. Analysis of 100 emergency aortocoronary bypass operations after percutaneous transluminal coronary angioplasty: which patients are at risk for large infarctions? Eur Heart J. 1991;12:946 51. Hillis et al 2011 ACCF/AHA CABG Guideline e707 294. Bonaros N, Hennerbichler D, Friedrich G, et al. Increased mortality and perioperative complications in patients with previous elective per- cutaneous coronary interventions undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2009;137:846 52. 295. Karthik S, Musleh G, Grayson AD, et al. Effect of avoiding cardiopul- monary bypass in non-elective coronary artery bypass surgery: a pro- pensity score analysis. Eur J Cardiothorac Surg. 2003;24:66 71. 296. Ladowski JS, Dillon TA, Deschner WP, et al. Durability of emergency coronary artery bypass for complications of failed angioplasty. Car- diovasc Surg. 1996;4:23 7. 297. Reinecke H, Roeder N, Schmid C, et al. Outcome of women is impaired in patients undergoing emergency coronary artery bypass grafting for failed PTCA. Z Kardiol. 2001;90:729 36. 298. Ghanta RK, Shekar PS, McGurk S, et al. Nonelective cardiac surgery in the elderly: is it justified? J Thorac Cardiovasc Surg. 2010; 140:103 9 e1. 299. Beller GA, Ragosta M. Decision making in multivessel coronary dis- ease: the need for physiological lesion assessment. J Am Coll Cardiol Intv. 2010;3:315 7. 300. Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010;55:2816 21. 301. Morice MC, Serruys PW, Kappetein AP, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Cir- culation. 2010;121:2645 53. 302. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961 72. 303. Feit F, Brooks MM, Sopko G, et al., BARI Investigators. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investi- gation Registry: comparison with the randomized trial. Circulation. 2000;101:2795 802. 304. King SBI, Barnhart HX, Kosinski AS, et al. Angioplasty or surgery for multivessel coronary artery disease: comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes: Emory Angioplasty versus Surgery Trial Inves- tigators. Am J Cardiol. 1997;79:1453 9. 305. Chakravarty T, Buch MH, Naik H, et al. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol. 2011;107: 360 6. 306. Grover FL, Shroyer AL, Hammermeister K, et al. A decade s expe- rience with quality improvement in cardiac surgery using the Veterans Affairs and Society of Thoracic Surgeons national databases. Ann Surg. 2001;234:464 72. 307. Kim YH, Park DW, Kim WJ, et al. Validation of SYNTAX (Synergy between PCI with TAXUS and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. J Am Coll Cardiol Intv. 2010;3:612 23. 308. Shahian DM, O Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1 coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88 1 Suppl:S2 22. 309. Shahian DM, O Brien SM, Normand SL, et al. Association of hospital coronary artery bypass volume with processes of care, mortality, mor- bidity, and the Society of Thoracic Surgeons composite quality score. J Thorac Cardiovasc Surg. 2010;139:273 82. 310. Welke KF, Peterson ED, Vaughan-Sarrazin MS, et al. Comparison of cardiac surgery volumes and mortality rates between the Society of Thoracic Surgeons and Medicare databases from 1993 through 2001. Ann Thorac Surg. 2007;84:1538 46. 311. Buszman PE, Kiesz SR, Bochenek A, et al. Acute and late outcomes of unprotected left main stenting in comparison with surgical revascular- ization. J Am Coll Cardiol. 2008;51:538 45. 312. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease: long-term CASS experience. Circulation. 1995;91:2325 34. 313. Chaitman BR, Fisher LD, Bourassa MG, et al. Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease: report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol. 1981;48:765 77. 314. Dzavik V, Ghali WA, Norris C, et al. Long-term survival in 11 661 patients with multivessel coronary artery disease in the era of stenting: a report from the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators. Am Heart J. 2001;142:119 26. 315. Takaro T, Hultgren HN, Lipton MJ, et al. The VA cooperative ran- domized study of surgery for coronary arterial occlusive disease II. Subgroup with significant left main lesions. Circulation. 1976;54: III107 17. 316. Takaro T, Peduzzi P, Detre KM, et al. Survival in subgroups of patients with left main coronary artery disease: Veterans Administration Coop- erative Study of Surgery for Coronary Arterial Occlusive Disease. Circulation. 1982;66:14 22. 317. Taylor HA, Deumite NJ, Chaitman BR, et al. Asymptomatic left main coronary artery disease in the Coronary Artery Surgery Study (CASS) registry. Circulation. 1989;79:1171 9. 318. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10 year results from ran- domised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563 70. 319. Capodanno D, Caggegi A, Miano M, et al. Global risk classification and clinical SYNTAX (Synergy between Percutaneous Coronary Inter- vention with TAXUS and Cardiac Surgery) score in patients undergoing percutaneous or surgical left main revascularization. J Am Coll Cardiol Intv. 2011;4:287 97. 320. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary- artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358:331 41. 321. Ellis SG, Tamai H, Nobuyoshi M, et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994 1996. Circulation. 1997;96: 3867 72. 322. Biondi-Zoccai GG, Lotrionte M, Moretti C, et al. A collaborative systematic review and meta-analysis on 1278 patients undergoing per- cutaneous drug-eluting stenting for unprotected left main coronary artery disease. Am Heart J. 2008;155:274 83. 323. Boudriot E, Thiele H, Walther T, et al. Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis [published correction appears in J Am Coll Cardiol. 2011;57:1792]. J Am Coll Cardiol. 2011;57:538 45. 324. Brener SJ, Galla JM, Bryant RI, et al. Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients. Am J Cardiol. 2008;101: 169 72. 325. Chieffo A, Morici N, Maisano F, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation. 2006;113: 2542 7. 326. Chieffo A, Magni V, Latib A, et al. 5 year outcomes following per- cutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions: the Milan experience. J Am Coll Cardiol Intv. 2010;3: 595 601. 327. Lee MS, Kapoor N, Jamal F, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug- eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol. 2006;47:864 70. 328. Makikallio TH, Niemela M, Kervinen K, et al. Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting. Ann Med. 2008;40: 437 43. 329. Naik H, White AJ, Chakravarty T, et al. A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. J Am Coll Cardiol Intv. 2009;2:739 47. 330. Palmerini T, Marzocchi A, Marrozzini C, et al. Comparison between coronary angioplasty and coronary artery bypass surgery for the treatment of unprotected left main coronary artery stenosis (the Bologna Registry). Am J Cardiol. 2006;98:54 9. 331. Park DW, Seung KB, Kim YH, et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5 year results from the MAIN- COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol. 2010; 56:117 24. 332. Rodes-Cabau J, Deblois J, Bertrand OF, et al. Nonrandomized com- parison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation. 2008;118:2374 81. 333. Sanmartin M, Baz JA, Claro R, et al. Comparison of drug-eluting stents versus surgery for unprotected left main coronary artery disease. Am J Cardiol. 2007;100:970 3. 334. Kappetein AP, Mohr FW, Feldman TE, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J. 2011;17:2125 34. 335. Seung KB, Park DW, Kim YH, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med. 2008;358:1781 92. 336. White AJ, Kedia G, Mirocha JM, et al. Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosis. J Am Coll Cardiol Intv. 2008;1:236 45. 337. Montalescot G, Brieger D, Eagle KA, et al. Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J. 2009;30:2308 17. 338. Lee MS, Tseng CH, Barker CM, et al. Outcome after surgery and percutaneous intervention for cardiogenic shock and left main disease. Ann Thorac Surg. 2008;86:29 34. 339. Lee MS, Bokhoor P, Park SJ, et al. Unprotected left main coronary disease and ST-segment elevation myocardial infarction: a contem- porary review and argument for percutaneous coronary intervention. J Am Coll Cardiol Intv. 2010;3:791 5. 340. Park SJ, Kim YH, Park DW, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med. 2011;364:1727. 341. Jones RH, Kesler K, Phillips HR, III, et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Car- diovasc Surg. 1996;111:1013 25. 342. Myers WO, Schaff HV, Gersh BJ, et al. Improved survival of sur- gically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) registry. J Thorac Cardiovasc Surg. 1989;97:487 95. 343. Smith PK, Califf RM, Tuttle RH, et al. Selection of surgical or percu- taneous coronary intervention provides differential longevity benefit. Ann Thorac Surg. 2006;82:1420 8. 344. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 1988;319:332 7. 345. Borger van der Burg AE, Bax JJ, Boersma E, et al. Impact of percu- taneous coronary intervention or coronary artery bypass grafting on outcome after nonfatal cardiac arrest outside the hospital. Am J Cardiol. 2003;91:785 9. 346. Deleted in proof. 347. Kaiser GA, Ghahramani A, Bolooki H, et al. Role of coronary artery surgery in patients surviving unexpected cardiac arrest. Surgery. 1975; 78:749 54. 348. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in man- agement decisions. J Thorac Cardiovasc Surg. 1998;116:997 1004. 349. Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900 7. 350. Sorajja P, Chareonthaitawee P, Rajagopalan N, et al. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting. Circulation. 2005;112: I311 6. 351. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascular- ization. Circulation. 1997;95:2037 43. 352. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circu- lation. 1983;68:785 95. 353. O Connor CM, Velazquez EJ, Gardner LH, et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25 year expe- rience from the Duke Cardiovascular Disease Databank). Am J Cardiol. 2002;90:101 7. 354. Phillips HR, O Connor CM, Rogers J. Revascularization for heart failure. Am Heart J. 2007;153:65 73. 355. Tarakji KG, Brunken R, McCarthy PM, et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation. 2006;113:230 7. 356. Tsuyuki RT, Shrive FM, Galbraith PD, et al. Revascularization in patients with heart failure. CMAJ. 2006;175:361 5. 357. Deleted in proof. 358. Deleted in proof. 359. Brener SJ, Lytle BW, Casserly IP, et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation. 2004;109:2290 5. 360. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352:2174 83. 361. Deleted in proof. 362. The BARI Investigators. influence of diabetes on 5 year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascular- ization Investigation (BARI). Circulation. 1997;96:1761 9. 363. The BARI Investigators. The final 10 year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49:1600 6. 364. Banning AP, Westaby S, Morice MC, et al. Diabetic and nondiabetic patients with left main and/or 3 vessel coronary artery disease: com- parison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol. 2010;55:1067 75. 365. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol. 2003;41:1293 304. 366. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082 9. 367. Malenka DJ, Leavitt BJ, Hearne MJ, et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circu- lation. 2005;112:I371 6. 368. Niles NW, McGrath PD, Malenka D, et al., Northern New England Cardiovascular Disease Study Group. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. J Am Coll Cardiol. 2001;37:1008 15. 369. Weintraub WS, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multi- vessel coronary artery disease. J Am Coll Cardiol. 1998;31:10 9. 370. Boden WE, O Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503 16. 371. Bonow RO, Maurer G, Lee KL, et al. Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction. N Engl J Med. 2011;364:1625. 372. Velazquez EJ, Lee KL, Deja MA, et al. Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. N Engl J Med. 2011;364:1616. 373. Brener SJ, Lytle BW, Casserly IP, et al. Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery. Eur Heart J. 2006;27: 413 8. 374. Gurfinkel EP, Perez dlH, Brito VM, et al. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery. Int J Cardiol. 2007;119:65 72. 375. Lytle BW, Loop FD, Taylor PC, et al. The effect of coronary reop- eration on the survival of patients with stenoses in saphenous vein bypass grafts to coronary arteries. J Thorac Cardiovasc Surg. 1993; 105:605 12. 376. Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary inter- vention versus coronary artery bypass graft surgery for patients with Hillis et al 2011 ACCF/AHA CABG Guideline e709 medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). J Am Coll Cardiol. 2001;38:143 9. 377. Pfautsch P, Frantz E, Ellmer A, et al. [Long-term outcome of therapy of recurrent myocardial ischemia after surgical revascularization]. Z Kardiol. 1999;88:489 97. 378. Sergeant P, Blackstone E, Meyns B, et al. First cardiological or car- diosurgical reintervention for ischemic heart disease after primary coronary artery bypass grafting. Eur J Cardiothorac Surg. 1998;14: 480 7. 379. Stephan WJ, O Keefe JH Jr, Piehler JM, et al. Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol. 1996;28:1140 6. 380. Subramanian S, Sabik JF, III, Houghtaling PL, et al. Decision-making for patients with patent left internal thoracic artery grafts to left anterior descending. Ann Thorac Surg. 2009;87:1392 8. 381. Weintraub WS, Jones EL, Morris DC, et al. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation. 1997;95:868 77. 382. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic bur- den: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283 91. 383. Cashin WL, Sanmarco ME, Nessim SA, et al. Accelerated progression of atherosclerosis in coronary vessels with minimal lesions that are bypassed. N Engl J Med. 1984;311:824 8. 384. Pijls NH, De Bruyne B, Peels K, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med. 1996;334:1703 8. 385. Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213 24. 386. Sawada S, Bapat A, Vaz D, et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgically revascu- larized patients with left ventricular dysfunction. J Am Coll Cardiol. 2003;42:2099 105. 387. TIME Investigators. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet. 2001;358:951 7. 388. Benzer W, Hofer S, Oldridge NB. Health-related quality of life in patients with coronary artery disease after different treatments for angina in routine clinical practice. Herz. 2003;28:421 8. 389. Bonaros N, Schachner T, Ohlinger A, et al. Assessment of health- related quality of life after coronary revascularization. Heart Surg Forum. 2005;8:E380 5. 390. Bucher HC, Hengstler P, Schindler C, et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ. 2000;321:73 7. 391. Favarato ME, Hueb W, Boden WE, et al. Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial. Int J Cardiol. 2007;116:364 70. 392. Hueb W, Lopes N, Gersh BJ, et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010;122:949 57. 393. Pocock SJ, Henderson RA, Seed P, et al. Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. 3 year follow-up in the Randomized Intervention Treatment of Angina (RITA) Trial. Circulation. 1996;94:135 42. 394. Pocock SJ, Henderson RA, Clayton T, et al. Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. J Am Coll Cardiol. 2000;35:907 14. 395. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359: 677 87. 396. Wijeysundera HC, Nallamothu BK, Krumholz HM, et al. Meta-anal- ysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med. 2010;152:370 9. 397. Schofield PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised con- trolled trial [published correction appears in Lancet. 1999;353:1714]. Lancet. 1999;353:519 24. 398. Aaberge L, Nordstrand K, Dragsund M, et al. Transmyocardial revas- cularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial. J Am Coll Cardiol. 2000;35:1170 7. 399. Burkhoff D, Schmidt S, Schulman SP, et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina Treatments-Lasers and Normal Therapies in Comparison. Lancet. 1999;354:885 90. 400. Allen KB, Dowling RD, DelRossi AJ, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg. 2000;119:540 9. 401. Stamou SC, Boyce SW, Cooke RH, et al. One-year outcome after combined coronary artery bypass grafting and transmyocardial laser revascularization for refractory angina pectoris. Am J Cardiol. 2002; 89:1365 8. 402. The VA Coronary Artery Bypass Surgery Cooperative Study Group. Eighteen-year follow-up in the Veterans Affairs Cooperative Study of Coronary Artery Bypass Surgery for stable angina. Circulation. 1992; 86:121 30. 403. Passamani E, Davis KB, Gillespie MJ, et al. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med. 1985;312:1665 71. 404. Frye RL, August P, Brooks MM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009; 360:2503 15. 405. Al Suwaidi J, Holmes DR Jr, Salam AM, et al. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta- analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J. 2004;147:815 22. 406. Brophy JM, Belisle P, Joseph L. Evidence for use of coronary stents. A hierarchical bayesian meta-analysis. Ann Intern Med. 2003;138: 777 86. 407. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quan- titative 20 year synopsis and a network meta-analysis [published cor- rection appears in Lancet. 2009;374:378]. Lancet. 2009;373:911 8. 408. Kastrati A, Mehilli J, Pache J, et al. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007; 356:1030 9. 409. Cecil WT, Kasteridis P, Barnes JW Jr, et al. A meta-analysis update: percutaneous coronary interventions. Am J Manag Care. 2008;14: 521 8. 410. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-anal- ysis. Circulation. 2005;111:2906 12. 411. Schomig A, Mehilli J, de Waha A, et al. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol. 2008;52:894 904. 412. Katritsis DG, Ioannidis JP. PCI for stable coronary disease. N Engl J Med. 2007;357:414 5. 413. Hambrecht R, Walther C, Mobius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004; 109:1371 8. 414. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorva- statin versus Revascularization Treatment Investigators. N Engl J Med. 1999;341:70 6. 415. Coronary angioplasty versus coronary artery bypass surgery: the Ran- domized Intervention Treatment of Angina (RITA) trial. Lancet. 1993; 341:573 80. 416. CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet. 1995;346:1179 84. 417. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217 25. 418. Writing Group for the Bypass Angioplasty Revascularization Investi- gation (BARI) Investigators. Five-year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. A multicenter randomized trial. JAMA. 1997;277: 715 21. 419. Carrie D, Elbaz M, Puel J, et al. Five-year outcome after coronary angioplasty versus bypass surgery in multivessel coronary artery dis- ease: results from the French Monocentric Study. Circulation. 1997; 96:II6. 420. Goy JJ, Eeckhout E, Burnand B, et al. Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet. 1994;343:1449 53. 421. Goy JJ, Eeckhout E, Moret C, et al. Five-year outcome in patients with isolated proximal left anterior descending coronary artery stenosis treated by angioplasty or left internal mammary artery grafting. A prospective trial. Circulation. 1999;99:3255 9. 422. Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI). N Engl J Med. 1994;331: 1037 43. 423. Henderson RA, Pocock SJ, Sharp SJ, et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet. 1998;352:1419 25. 424. Hueb WA, Soares PR, Almeida De OS, et al. Five-year follow-up of the medicine, angioplasty, or surgery study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation. 1999;100:II107 13. 425. King SB III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med. 1994;331: 1044 50. 426. King SBI, Kosinski AS, Guyton RA, et al. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol. 2000;35:1116 21. 427. Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1 year follow-up. ERACI Group. J Am Coll Cardiol. 1993;22:1060 7. 428. Rodriguez A, Mele E, Peyregne E, et al. Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). J Am Coll Cardiol. 1996;27:1178 84. 429. Wahrborg P. Quality of life after coronary angioplasty or bypass surgery. 1 year follow-up in the Coronary Angioplasty versus Bypass Revascularization investigation (CABRI) trial. Eur Heart J. 1999;20: 653 8. 430. Coronary artery bypass surgery versus percutaneous coronary inter- vention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial. Lancet. 2002;360:965 70. 431. Cisowski M, Drzewiecki J, Drzewiecka-Gerber A, et al. Primary stenting versus MIDCAB: preliminary report-comparision of two methods of revascularization in single left anterior descending coronary artery stenosis. Ann Thorac Surg. 2002;74:S1334 9. 432. Cisowski M, Drzewiecka-Gerber A, Ulczok R, et al. Primary direct stenting versus endoscopic atraumatic coronary artery bypass surgery in patients with proximal stenosis of the left anterior descending coronary artery a prospective, randomised study. Kardiol Pol. 2004; 61:253 61. 433. Diegeler A, Thiele H, Falk V, et al. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Engl J Med. 2002;347:561 6. 434. Drenth DJ, Veeger NJ, Winter JB, et al. A prospective randomized trial comparing stenting with off-pump coronary surgery for high-grade stenosis in the proximal left anterior descending coronary artery: three-year follow-up. J Am Coll Cardiol. 2002;40:1955 60. 435. Drenth DJ, Veeger NJ, Middel B, et al. Comparison of late (four years) functional health status between percutaneous transluminal angioplasty intervention and off-pump left internal mammary artery bypass grafting for isolated high-grade narrowing of the proximal left anterior descending coronary artery. Am J Cardiol. 2004;94:1414 7. 436. Eefting F, Nathoe H, van Dijk D, et al. Randomized comparison between stenting and off-pump bypass surgery in patients referred for angioplasty. Circulation. 2003;108:2870 6. 437. Goy JJ, Kaufmann U, Goy-Eggenberger D, et al. A prospective ran- domized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: the SIMA trial. Stenting vs Internal Mammary Artery. Mayo Clin Proc. 2000;75:1116 23. 438. Hueb W, Soares PR, Gersh BJ, et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004;43:1743 51. 439. Kim JW, Lim DS, Sun K, et al. Stenting or MIDCAB using minister- notomy for revascularization of proximal left anterior descending artery? Int J Cardiol. 2005;99:437 41. 440. Pohl T, Giehrl W, Reichart B, et al. Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I study. Catheter Cardiovasc Interv. 2004;62:323 30. 441. Reeves BC, Angelini GD, Bryan AJ, et al. A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery. Health Technol Assess. 2004;8:1 43. 442. Rodriguez A, Bernardi V, Navia J, et al., ERACI II Investigators. Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30 day and one-year follow-up results. J Am Coll Cardiol. 2001;37:51 8. 443. Rodriguez AE, Baldi J, Fernandez PC, et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol. 2005;46:582 8. 444. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117 24. 445. Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005; 46:575 81. 446. Stroupe KT, Morrison DA, Hlatky MA, et al. Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary inter- vention for revascularization of high-risk patients. Circulation. 2006; 114:1251 7. 447. Thiele H, Oettel S, Jacobs S, et al. Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: a 5 year follow-up. Circulation. 2005;112: 3445 50. 448. Hong SJ, Lim DS, Seo HS, et al. Percutaneous coronary intervention with drug-eluting stent implantation vs. minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis. Catheter Cardiovasc Interv. 2005; 64:75 81. 449. Thiele H, Neumann-Schniedewind P, Jacobs S, et al. Randomized comparison of minimally invasive direct coronary artery bypass surgery versus sirolimus-eluting stenting in isolated proximal left anterior descending coronary artery stenosis. J Am Coll Cardiol. 2009; 53:2324 31. 450. Bravata DM, Gienger AL, McDonald KM, et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery. Ann Intern Med. 2007;147: 703 16. 451. Hlatky MA, Boothroyd DB, Bravata DM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multi- vessel disease: a collaborative analysis of individual patient data from ten randomised trials. Lancet. 2009;373:1190 7. 452. Briguori C, Condorelli G, Airoldi F, et al. Comparison of coronary drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol. 2007;99:779 84. 453. Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug- eluting stents for patients with multivessel coronary artery disease. Circulation. 2007;116:I200 6. Hillis et al 2011 ACCF/AHA CABG Guideline e711 454. Lee MS, Jamal F, Kedia G, et al. Comparison of bypass surgery with drug-eluting stents for diabetic patients with multivessel disease. Int J Cardiol. 2007;123:34 42. 455. Park DW, Yun SC, Lee SW, et al. Long-term mortality after percuta- neous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation. 2008;117:2079 86. 456. Tarantini G, Ramondo A, Napodano M, et al. PCI versus CABG for multivessel coronary disease in diabetics. Catheter Cardiovasc Interv. 2009;73:50 8. 457. Varani E, Balducelli M, Vecchi G, et al. Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical re- vascularization in patients with multivessel coronary artery disease: one-year clinical results and total treatment costs. J Invasive Cardiol. 2007;19:469 75. 458. Yang JH, Gwon HC, Cho SJ, et al. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease. Ann Thorac Surg. 2008;85: 65 70. 459. Yang ZK, Shen WF, Zhang RY, et al. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. J Interv Cardiol. 2007;20:10 6. 460. Benedetto U, Melina G, Angeloni E, et al. Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24 268 patients. Eur J Cardiothorac Surg. 2009;36: 611 5. 461. Deleted in proof. 462. Deleted in proof. 463. Ragosta M, Dee S, Sarembock IJ, et al. Prevalence of unfavorable angiographic characteristics for percutaneous intervention in patients with unprotected left main coronary artery disease. Catheter Car- diovasc Interv. 2006;68:357 62. 464. Chieffo A, Park SJ, Valgimigli M, et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multi-center registry. Circulation. 2007;116:158 62. 465. Tamburino C, Capranzano P, Capodanno D, et al. Plaque distribution patterns in distal left main coronary artery to predict outcomes after stent implantation. J Am Coll Cardiol Intv. 2010;3:624 31. 466. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. Circu- lation. 2006;113:156 75. 467. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutane- ous coronary intervention (updating the 2005 guideline and 2007 focused update) [published correction appears in Circulation 2010;121: e257]. Circulation. 2009;120:2271 306. 468. Ben-Gal Y, Mohr R, Braunstein R, et al. Revascularization of left anterior descending artery with drug-eluting stents: comparison with minimally invasive direct coronary artery bypass surgery. Ann Thorac Surg. 2006;82:2067 71. 469. Fraund S, Herrmann G, Witzke A, et al. Midterm follow-up after minimally invasive direct coronary artery bypass grafting versus per- cutaneous coronary intervention techniques. Ann Thorac Surg. 2005; 79:1225 31. 470. Goy JJ, Kaufmann U, Hurni M, et al. 10 year follow-up of a pro- spective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial. J Am Coll Cardiol. 2008;52:815 7. 471. Aziz O, Rao C, Panesar SS, et al. Meta-analysis of minimally invasive internal thoracic artery bypass versus percutaneous revascularisation for isolated lesions of the left anterior descending artery. BMJ. 2007; 334:617. 472. Jaffery Z, Kowalski M, Weaver WD, et al. A meta-analysis of ran- domized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery. Eur J Cardiothorac Surg. 2007;31:691 7. 473. Kapoor JR, Gienger AL, Ardehali R, et al. Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. J Am Coll Cardiol Intv. 2008;1:483 91. 474. Abizaid A, Costa MA, Centemero M, et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Re- vascularization Therapy Study (ARTS) trial. Circulation. 2001;104: 533 8. 475. Kapur A, Hall RJ, Malik IS, et al. Randomized comparison of percu- taneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1 year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol. 2010;55: 432 40. 476. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Ep- idemiology and Prevention. Circulation. 2003;108:2154 69. 477. Roger VL, Go AS, Lloyd-Jones DM, et al; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcom- mittee. Heart disease and stroke statistics 2011 update: a report from the American Heart Association. Circulation. 2011;123:e18 209. 478. Sedlis SP, Jurkovitz CT, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. Am J Cardiol. 2009;104:1647 53. 479. Hemmelgarn BR, Southern D, Culleton BF, et al. Survival after coronary revascularization among patients with kidney disease. Circu- lation. 2004;110:1890 5. 480. Reddan DN, Szczech LA, Tuttle RH, et al. Chronic kidney disease, mortality, and treatment strategies among patients with clinically sig- nificant coronary artery disease. J Am Soc Nephrol. 2003;14:2373 80. 481. Bae KS, Park HC, Kang BS, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary artery disease and diabetic nephropathy: a single center experience. Korean J Intern Med. 2007;22:139 46. 482. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation. 2002;106:2207 11. 483. Ix JH, Mercado N, Shlipak MG, et al. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS). Am Heart J. 2005; 149:512 9. 484. Koyanagi T, Nishida H, Kitamura M, et al. Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients. Ann Thorac Surg. 1996;61:1793 6. 485. Szczech LA, Reddan DN, Owen WF, et al. Differential survival after coronary revascularization procedures among patients with renal insuf- ficiency. Kidney Int. 2001;60:292 9. 486. Jones EL, Craver JM, Guyton RA, et al. Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol. 1983;51:7 12. 487. Bell MR, Bailey KR, Reeder GS, et al. Percutaneous transluminal angioplasty in patients with multivessel coronary disease: how important is complete revascularization for cardiac event-free survival? J Am Coll Cardiol. 1990;16:553 62. 488. Bourassa MG, Yeh W, Holubkov R, et al. Long-term outcome of patients with incomplete vs complete revascularization after multi- vessel PTCA. A report from the NHLBI PTCA Registry. Eur Heart J. 1998;19:103 11. 489. Faxon DP, Ghalilli K, Jacobs AK, et al. The degree of revascularization and outcome after multivessel coronary angioplasty. Am Heart J. 1992;123:854 9. 490. Berger PB, Velianou JL, Aslanidou VH, et al. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy. Results from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol. 2001;38:1440 9. 491. Gioia G, Matthai W, Gillin K, et al. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting. Catheter Car- diovasc Interv. 2007;70:26 33. 492. O Keefe JH Jr, Allan JJ, McCallister BD, et al. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ven- tricular ejection fraction or 40%. Am J Cardiol. 1993;71:897 901. 493. Cole JH, Jones EL, Craver JM, et al. Outcomes of repeat revascular- ization in diabetic patients with prior coronary surgery. J Am Coll Cardiol. 2002;40:1968 75. 494. Choudhry NK, Singh JM, Barolet A, et al. How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials. Am J Med. 2005; 118:465 74. 495. Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST- elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet. 2002;360:743 51. 496. Fox KA, Clayton TC, Damman P, et al. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST- segment elevation acute coronary syndrome a meta-analysis of indi- vidual patient data. J Am Coll Cardiol. 2010;55:2435 45. 497. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol. 2007;6:734 9. 498. Leon MB, Baim DS, Popma JJ, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med. 1998; 339:1665 71. 499. Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in ran- domized clinical trials of drug-eluting stents. N Engl J Med. 2007;356: 1020 9. 500. McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug- eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519 21. 501. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA. 2007;297:159 68. 502. Bridges CR, Horvath KA, Nugent WC, et al. The Society of Thoracic Surgeons practice guideline series: transmyocardial laser revascular- ization. Ann Thorac Surg. 2004;77:1494 502. 503. Vineberg AM. Development of an anastomosis between the coronary vessels and a transplanted internal mammary artery. Can Med Assoc J. 